FindTrial
Sign In

Risk factor assessment and intervention strategies for re-fracture and death after OVCF due to vertebroplasty

The influence of WeChat platform management and teripaptide on the recurrence of fracture and death after OVCF vertebroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038197
Enrollment
Unknown
Registered
2020-09-13
Start date
2020-09-19
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal fracture

Interventions

3:Tripopeptide
4:normal saline
1:WeChat management
2:Self-medication

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: Ages 50-100;PVP or PKP were performed in OVCF patients with pain symptoms.

Exclusion criteria

Exclusion criteria: 1. PVP or PKP for compression fracture due to tumor; 2. A prior history of vertebroplasty or spinal internal fixation; 3. Spinal infection; 4. Resident family member cannot complete WeChat related procedure;Hypercalcemia, hypocalcemia or hyperuricemia; 5. Esophageal anomalies with delayed emptying; 6. No ability to stand or sit for less than 30 minutes.

Design outcomes

Primary

MeasureTime frame
BMD;refracture;death;—

Secondary

MeasureTime frame
pain;adverse events;—

Countries

China

Contacts

Public ContactZhengxue Quan

The First Affiliated Hospital of Chongqing Medical University

quanzx18@126.com+86 23- 890112111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026